| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447082 | European Journal of Cancer | 2011 | 8 Pages |
Abstract
In the treatment of resectable colorectal liver metastases, the addition of neo-adjuvant chemotherapy could be cost-effective because it makes it possible to avoid hepatic resection in patients who do not respond to the neo-adjuvant approach; however, the life-expectancy of the two strategies is very similar.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Giorgio Ercolani, Alessandro Cucchetti, Matteo Cescon, Eugenia Peri, Giovanni Brandi, Massimo Del Gaudio, Matteo Ravaioli, Matteo Zanello, Antonio Daniele Pinna,